Efficacy and Safety of PEG-rhG-CSF Secondary Prophylaxis vs. Therapeutic Administration in Patients With Ovarian Cancer
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03858166 |
|
Recruitment Status : Unknown
Verified February 2019 by Beihua Kong, Shandong University.
Recruitment status was: Recruiting
First Posted : February 28, 2019
Last Update Posted : February 28, 2019
|
Sponsor:
Shandong University
Information provided by (Responsible Party):
Beihua Kong, Shandong University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Estimated Primary Completion Date : | December 31, 2019 |
| Estimated Study Completion Date : | December 31, 2019 |